April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Sustained Neuroprotection After a Single Intravitreal Injection of PGJ2 in a Rodent Model of NAION
Author Affiliations & Notes
  • V. Touitou
    Ophthalmology, Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, Maryland
    Ophthalmology,
    Univ of Maryland Sch of Medicine, Baltimore, Maryland
  • M. A. Johnson
    Ophthal and Vis Science,
    Univ of Maryland Sch of Medicine, Baltimore, Maryland
  • N. R. Miller
    Ophthalmology, Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, Maryland
  • Y. Guo
    Ophthalmology,
    Univ of Maryland Sch of Medicine, Baltimore, Maryland
  • D. Bernstein
    Ophthalmology,
    Univ of Maryland Sch of Medicine, Baltimore, Maryland
  • S. L. Bernstein
    Ophthalmology,
    Univ of Maryland Sch of Medicine, Baltimore, Maryland
  • Footnotes
    Commercial Relationships  V. Touitou, None; M.A. Johnson, None; N.R. Miller, None; Y. Guo, None; D. Bernstein, None; S.L. Bernstein, None.
  • Footnotes
    Support  NIH grants 2R01EY015304 1 and R01EY019529-01
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 3838. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      V. Touitou, M. A. Johnson, N. R. Miller, Y. Guo, D. Bernstein, S. L. Bernstein; Sustained Neuroprotection After a Single Intravitreal Injection of PGJ2 in a Rodent Model of NAION. Invest. Ophthalmol. Vis. Sci. 2010;51(13):3838.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Prostaglandin J2 (PGJ2) has been proposed as a potential neuroprotective agent. We wanted to evaluate the toxicity and the efficacy of a single intravitreal (IVT) injection of PGJ2 in a rodent model of nonarteritic anterior ischemic optic neuropathy (NAION).

Methods: : We used the laser-activated rose Bengal induction method to produce NAION in Long-Evans rats. We also evaluated IVT-PGJ2 retinal toxicity. Following induction, PGJ2 was intravitreally injected in the treatment group. IVT phosphate buffered saline (PBS) was used as a control. Functional studies (VEP) were performed at baseline and at 7 days post-treatment to assess retinal and axonal status. Structural studies included immunohistochemical (IHC) and electron microscopic (EM) analysis of the optic nerve (ON), and stereologic analysis of changes in retinal ganglion cell (RGC) numbers 30 days post-induction.

Results: : Toxicity studies

Conclusions: : A single IVT injection of PGJ2 produces no evidence of retinal or ON toxicity by either functional or structural analysis in healthy adult rats. The intravitreal route of administration enables delivery of a high concentration of the drug in a low volume, with minimal risks from systemic side effects. Additionally, a single IVT injection of PGJ2 preserved RGCs and their axons and provided sustained neuroprotection for at least 1 month following the initial ischemic event in a rodent model of NAION. Ongoing studies are being conducted to evaluate whether a similar effect is observed in primates.

Keywords: neuroprotection • optic nerve • ischemia 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×